Faithward Advisors’s MetLife MET Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$301K Buy
+3,557
New +$287K 0.04% 273
2026
Q1
Sell
-3,595
Closed -$284K 301
2025
Q4
$284K Sell
3,595
-1,037
-22% -$82.1K 0.04% 269
2025
Q3
$382K Sell
4,632
-327
-7% -$25.7K 0.06% 219
2025
Q2
$399K Sell
4,959
-85
-2% -$6.56K 0.06% 188
2025
Q1
$405K Sell
5,044
-76
-1% -$6.32K 0.07% 176
2024
Q4
$419K Buy
5,120
+197
+4% +$16.4K 0.07% 169
2024
Q3
$406K Sell
4,923
-909
-16% -$67.9K 0.07% 192
2024
Q2
$409K Buy
5,832
+502
+9% +$35.8K 0.07% 180
2024
Q1
$395K Buy
5,330
+392
+8% +$27.3K 0.07% 179
2023
Q4
$325K Buy
4,938
+806
+20% +$50.4K 0.07% 142
2023
Q3
$250K Buy
+4,132
New +$257K 0.06% 150

Other funds holding MET

Faithward Advisors's MET Position: Q2 2026 in Review

Faithward Advisors opened a new position in MetLife (MET) in Q2 2026: 3,557 shares worth $301K. The stake represents 0.04% of the portfolio and ranks #273 among its holdings. This is a return to the name: Faithward Advisors previously reported a position in MET as recently as Q4 2025.

Faithward Advisors first reported a position in MET in Q3 2023 and has held it in 11 quarters since. The position peaked at $419K in Q4 2024. 1,449 funds tracked by Wall St. Rank hold MET as of Q2 2026.

  • Faithward Advisors held 3,557 shares of MetLife worth $301K as of Q2 2026.
  • MetLife was a new Faithward Advisors position in Q2 2026.
  • MetLife made up 0.04% of Faithward Advisors's portfolio in Q2 2026, its #273 holding.
  • Faithward Advisors first reported a position in MetLife in Q3 2023 and has held it in 11 quarters since.
  • Faithward Advisors's MetLife position peaked at $419K in Q4 2024.
  • 1,449 funds tracked by Wall St. Rank held MetLife as of Q2 2026.

Based on Faithward Advisors's 13F filing for Q2 2026, filed 12 Aug 2026.